Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
This study has been completed.
Johns Hopkins University
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Jeffrey Fadrowski, Johns Hopkins University
First received: December 9, 2008
Last updated: August 31, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||August 2015|
|Primary Completion Date:||August 2015 (Final data collection date for primary outcome measure)|